How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA2LEN statement

Philippe‐Jean Bousquet(Inserm), Torsten Zuberbier(Humboldt-Universität zu Berlin), Andrew Briggs(University of Glasgow), Pascal Demoly(Inserm), Philippe Devillier(Inserm), Giorgio Walter Canonica(Humanitas University), Désirée Larenas‐Linnemann(Hospital Médica Sur), C Baena-Cagnani(Universidad Católica de Córdoba), Claus Bachert(University Hospital Münster), Thomas B. Casale(University of South Florida), Holger J. Schünemann(Humanitas University), Giovanni Passalacqua(Ospedale Policlinico San Martino), Peter Howarth(Age UK), F. Estelle R. Simons(University of Manitoba), Nikolaos G. Papadopoulos(National and Kapodistrian University of Athens), Ronald Dahl(Aarhus University Hospital), J. Brozek(Asthma Association), P. Schmid-Grendelmeier(ENT and Allergy), S. R. Durham(Applied Research in Acoustics (United States)), T. Bieber(University of Bonn), M Calderon, J. M. Antó(Universitat Pompeu Fabra), K. H. Carlsen(Oslo University Hospital), Roy Gerth van Wijk(Erasmus MC), H.‐J. Malling(Copenhagen University Hospital), Karl‐Christian Bergmann(Charité - Universitätsmedizin Berlin)
Cited by 77


Related Papers